Immunization schedules for children and adults

The following is the Department of Health’s recommended immunization schedules for healthy children and adults. At any time, you can request an immunization report for yourself or your child.

Recommended Immunization Schedule for Children 

Immunizations are an important part of keeping children healthy. These immunizations begin when your child is two months old. Your paediatrician may recommend slight variations to this schedule based on their knowledge of your child. Now available is the

.

Child’s age 

Immunizations to protect against 

2 months 

Rotavirus, Diphtheria, Tetanus & Pertussis (DTaP), Haemophilus B, Polio, Pneumococcal 

4 months 

Rotavirus, Diphtheria, Tetanus & Pertussis (DTaP), Haemophilus B, Polio, Pneumococcal 

6 months 

Diphtheria, Tetanus & Pertussis (DTaP), Haemophilus B, Polio, Pneumococcal 

7 months 

Hepatitis B 

8 months 

Hepatitis B 

12 months 

Hepatitis B 

15 months 

Measles, Mumps & Rubella (MMR) 

15 – 18 months 

Diphtheria, Tetanus & Pertussis (DTaP), Haemophilus B, Polio, Pneumococcal 

24 months 

Chicken Pox 

4 – 6 years 

Diphtheria, Tetanus & Pertussis (DTaP), Polio, Measles, Mumps, Rubella (MMR)

11 years

HPV

11 – 18 years 

Tetanus Diphtheria (Tdap)

Recommended Adult Immunization Schedule 

The Adult immunization and travel health clinic offers immunization and an internationally-recognized certificate of vaccination.

Adult’s age 

Recommended immunizations for those that lack evidence of immunity 

Recommended immunizations if some other risk factor is present 

19-49 years 

Tetanus, diphtheria, pertussis/TdTdap 

(1 dose Td booster every 10 years or substitute 1 time dose of Tdap for Td booster) 

 

Human papillomavirus/HPV (3 doses males and females 19-26 years of age) 

 

Measles, mumps, rubella/MMR (1 or 2 doses) 

 

Varicella (1 dose) 

 

Influenza (1 dose annually) 

Pneumococcal/polysaccharide (1 or 2 doses) 

 

Hepatitis A (2 doses – 0, 6-12 months) 

 

Hepatitis B (3 doses – 0, 1-2, 4-6 months) 

 

Meningococcal (1 or more doses) 

50-64 years 

Tetanus, diphtheria, pertussis/TdTdap 

(1 dose Td booster every 10 years or substitute 1 time dose of Tdap for Td booster) 

 

Influenza (1 dose annually) 

 

Zoster (1 dose 60-79 years of age) 

 

Measles, mumps, rubella/MMR (1 dose) 

 

Varicella (1 dose) 

 

Pneumococcal/polysaccharide (1 or 2 doses) 

 

Hepatitis A (2 doses – 0, 6-12 months) 

 

Hepatitis B (3 doses – 0, 1-2, 4-6 months) 

 

Meningococcal (1 or more doses) 

65 years and older 

Tetanus, diphtheria, pertussis/TdTdap 

(1 dose Td booster every 10 years or substitute 1 time dose of Tdap for Td booster) 

 

Influenza (1 dose annually) 

 

Zoster (1 dose 60-79 years of age) 

 

Pneumococcal/polysaccharide (1 dose) 

Measles, mumps, rubella/MMR (1 dose) 

 

Hepatitis A (2 doses – 0, 6-12 months) 

 

Hepatitis B (3 doses – 0, 1-2, 4-6 months) 

 

Meningococcal (1 or more doses) 

Please note the following: 

1. Adults without documentation of having received a series of DTaP, DTP, DT or adult Td should receive a complete series of 3 doses:  

  • Single dose of Tdap;  

  • Td at least 4 weeks after the Tdap dose;  

  • Second dose of Td at least 6 months after the Td dose.  

Tdap is recommended during each pregnancy in the second or third trimester or in the immediate postpartum period.  

2. Recommended for females and males ages 18 through 26 years. Given at 0, 2 months and 6 months. The 2nd dose should be given 2 months after the 1st dose and the 3rd dose should be given 4 months after the 2nd dose. Vaccination is not recommended for pregnant women.  

3. People born before 1957 are usually considered immune. Contraindicated during pregnancy or within 4 weeks of a possible pregnancy  

4. Consider in adults without evidence of immunity (lack of documentation of vaccination or have no history of prior infection). Contraindicated during pregnancy or within 2 months of a possible pregnancy. Dosage is subject to change pending vaccine manufacturing type.  

5. Annual influenza vaccination is recommended for all adults.  

6. Recommended for persons 60 to 79 years of age. There is significant decrease in vaccine effectiveness for person over the age of 80 years. The vaccine is contraindicated for persons that have received the varicella vaccine.  

7. Recommended for persons 65 years and older and adults of any age who have a chronic illness.  

8. Recommended for persons with chronic liver disease, injecting and non-injecting drug users, men who have sex with men, and people who receive clotting-factor concentrates. Minimal interval between doses is 6 months.  

9. Recommended for previously unvaccinated adult, including injecting and non-injecting drug users, men who have sex with men, persons with multiple sex partners, persons with end-stage renal disease including dialysis and persons with occupational risks.  

10. Recommended for adults at increased risk of infection and certain high-risk persons (functional or anatomic asplenia, HIV infection, dormitory living, travel to at risk areas)